PanGen Biotech Inc. (KOSDAQ:222110)
South Korea · Delayed Price · Currency is KRW 4,805.00
-25.00 (-0.52%)
At close: Sep 23, 2026
PanGen Biotech Market Cap
PanGen Biotech has a market cap or net worth of 64.94 billion as of September 25, 2026. Its market cap has decreased by -21.37% in one year.
Market Cap
64.94B
Enterprise Value
52.89B
Revenue
14.18B
Ranking
n/a
PE Ratio
62.25
Stock Price
4,805.00
ChartMarket Cap Chart
Since March 11, 2016, PanGen Biotech's market cap has decreased from 171.29B to 64.94B, a decrease of -62.09%. That is a compound annual growth rate of -8.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 64.94B | -14.07% |
| Dec 30, 2025 | 75.57B | 2.79% |
| Dec 30, 2024 | 73.52B | 0.08% |
| Dec 28, 2023 | 73.46B | 5.85% |
| Dec 29, 2022 | 69.40B | -30.44% |
| Dec 30, 2021 | 99.78B | 1.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIO-FD&C | 79.74B |
| Naturalendo Tech | 74.67B |
| CTCBIO | 71.85B |
| IMGT Co.,Ltd. | 69.86B |
| SunBio,Inc. | 68.77B |
| NovMetaPharma | 67.93B |
| ABION | 60.91B |
| Psomagen | 59.92B |